Clinical Trial Details
EORTC-40991
Back to Clinical Trials Database
Phase III Randomized Study of Adjuvant Immunotherapy with Monoclonal Antibody 17-1A versus no Adjuvant Therapy Following Resection for Stage II (Modified Astler Coller B2) Adenocarcinoma of the Colon
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 03-Oct-2000 Date Step1 close: 08-Feb-2001 |
| Data management at EORTC | No |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 2100 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
